← Back to headlines
Lantern Pharma Outlines Open Medicine AI Spin-Out Amid $10B Market Outlook
Lantern Pharma has detailed its plans for the spin-out of Open Medicine AI, projecting a market outlook of $10 billion by 2030-2031.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
